NUVISAN

NUVISAN is a Contract Research and Manufacturing Organization (CRO/CDMO) with six production sites in Germany and France. NUVISAN provides unique, high-quality, and tailored integrated solutions in the drug discovery and development value chain (from target to patient). With over 40 years of experience and more than 1,000 employees, NUVISAN supports its biotech startups, pharmaceutical companies, and venture capital partners in discovering, developing, and bringing next-generation drugs to market. NUVISAN ICB encompasses all functions in Berlin, offering end-to-end solutions from target identification to preclinical candidates and IND, covering protein technologies, structural biology, high-throughput screening, computational and medicinal chemistry, pharmacology, translational research, drug metabolism and pharmacokinetics, as well as toxicology.